将药物配方添加剂推进到具有释放介导介层的精密添加剂
Sebastian Wieczorek, André Dallmann, Zdravko Kochovski1
1Soft Matter and Functional Materials, Helmholtz-Zentrum Berlin für Materialien und Energie , Hahn-Meitner-Platz 1, Berlin, Germany.
Journal of the American Chemical Society
|July 12, 2016
概括
使用棕酸聚乙烯醇 (Pal-PEG) 和特定的新药配方添加剂精确控制药物释放. 这项创新提高了先进治疗应用的药物溶解性和递送动力学.
科学领域:
- 药物输送系统
- 聚合物化学
- 生物结合物化学
背景情况:
- 开发有效的药物输送系统对于治疗成功至关重要.
- 目前的配方通常面临药物溶解性,稳定性和受控释放方面的挑战.
- 聚乙烯糖醇 (PEG) 由于其溶解性和生物相容性而广泛使用,而疏水成分可以帮助药物加载.
研究的目的:
- 开发新的两药物配方添加剂,以精确控制药物释放特征.
- 创建一个增强药物溶解性的系统,并实现高药物载荷能力.
- 在调节药物激活动态方面研究定制的作用.
主要方法:
- 基于棕酸改性聚乙烯糖醇 (Pal-PEG) 的合成两性添加剂.
- 包含一种通过组合方法在疏水-疏水界面选择的药物结合.
- 使用开发的添加剂制造了一种光敏感剂药物.
- 评估药物载荷,溶解度和释放动力学,包括激活调制.
主要成果:
- 帕尔-PEG添加剂实现了高药物的有效载荷,接近1:1的比例.
- 这种配方成功使光敏剂在水中溶解.
- 微调接口层允许调节药物激活动力学.
- 这种可以精确调节药物释放特征.
结论:
- 基于Pal-PEG的添加剂与量身定制的为先进药物配方提供了多功能平台.
- 这种方法提供了增强的溶解性,高药物负载和可调节的释放/激活动力学.
- 该系统有望提高包括光敏感剂在内的各种治疗剂的有效性和输送.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
82
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
82
Modified-Release Drug Delivery Systems: Rate-Programmed II
72
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
72
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
297
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
297
Modified-Release Drug Delivery Systems: Classification
192
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
192
Modified-Release Drug Delivery Systems: Site-Targeted
73
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
73
Modified-Release Drug Delivery Systems: Stimuli-Activated
74
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
74


